Nordic Group BV   Report issue

For profit Phase 1
Founded: Trondheim Norway (1967)
Status: No NME R&D (1967)

Organization Overview

First Clinical Trial
2013
NCT01928524
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now